JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) Short Interest Down 17.8% in June

JCR Pharmaceuticals Co., Ltd. (OTCMKTS:JCRRF) was the recipient of a large decrease in short interest in the month of June. As of June 15th, there was short interest totalling 447,000 shares, a decrease of 17.8% from the May 31st total of 544,000 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

JCR Pharmaceuticals Stock Performance

Shares of OTCMKTS JCRRF remained flat at $5.22 during midday trading on Tuesday. JCR Pharmaceuticals has a 12-month low of $5.22 and a 12-month high of $6.20. The company has a 50 day moving average price of $5.22 and a 200 day moving average price of $6.69.

JCR Pharmaceuticals Company Profile

JCR Pharmaceuticals Co, Ltd., together with its subsidiaries, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and short stature; IZCARGO to treat Mucopolysaccharidosis type II; Agalsidase Beta BS I.V.